Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

EPA:CROS - Euronext Paris - Matif - FR0000050395 - Common Stock - Currency: EUR

11  0 (0%)

Fundamental Rating

4

CROS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. While CROS has a great health rating, its profitability is only average at the moment. CROS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CROS was profitable.
CROS had a positive operating cash flow in the past year.
CROS had positive earnings in 4 of the past 5 years.
In multiple years CROS reported negative operating cash flow during the last 5 years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.47%, CROS is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
The Return On Equity of CROS (1.86%) is better than 60.32% of its industry peers.
CROS's Return On Invested Capital of 0.59% is in line compared to the rest of the industry. CROS outperforms 49.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CROS is below the industry average of 4.17%.
The last Return On Invested Capital (0.59%) for CROS is above the 3 year average (0.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROIC 0.59%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 150.55%, CROS belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
The Operating Margin of CROS (86.10%) is better than 98.41% of its industry peers.
CROS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 81.23%, CROS belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
In the last couple of years the Gross Margin of CROS has grown nicely.
Industry RankSector Rank
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

More info and screens

7

2. Health

2.1 Basic Checks

CROS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CROS remains at a similar level compared to 1 year ago.
The number of shares outstanding for CROS remains at a similar level compared to 5 years ago.
CROS has a better debt/assets ratio than last year.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.27 indicates that CROS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.27, CROS belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
CROS has a debt to FCF ratio of 2.27. This is a good value and a sign of high solvency as CROS would need 2.27 years to pay back of all of its debts.
The Debt to FCF ratio of CROS (2.27) is better than 96.83% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that CROS is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.04, CROS belongs to the best of the industry, outperforming 87.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Altman-Z 4.27
ROIC/WACC0.08
WACC7.81%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.28 indicates that CROS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.28, CROS is in line with its industry, outperforming 55.56% of the companies in the same industry.
CROS has a Quick Ratio of 1.28. This is a normal value and indicates that CROS is financially healthy and should not expect problems in meeting its short term obligations.
CROS has a better Quick ratio (1.28) than 73.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 226.76% over the past year.
Looking at the last year, CROS shows a decrease in Revenue. The Revenue has decreased by -6.15% in the last year.
CROS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.96% yearly.
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 78.57, which means the current valuation is very expensive for CROS.
Compared to the rest of the industry, the Price/Earnings ratio of CROS is on the same level as its industry peers.
CROS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.87.
Industry RankSector Rank
PE 78.57
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CROS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 63.14
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The decent profitability rating of CROS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

CROS has a yearly dividend return of 0.91%, which is pretty low.
CROS's Dividend Yield is comparable with the industry average which is at 7.08.
Compared to an average S&P500 Dividend Yield of 2.46, CROS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of CROS is nicely growing with an annual growth rate of 125.18%!
Dividend Growth(5Y)125.18%
Div Incr Years1
Div Non Decr Years1
CROS.PA Yearly Dividends per shareCROS.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
CROS.PA Yearly Income VS Free CF VS DividendCROS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

More info and screens

CROSSWOOD

EPA:CROS (4/22/2025, 7:00:00 PM)

11

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap116.93M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend0.11
Dividend Growth(5Y)125.18%
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 78.57
Fwd PE N/A
P/S 116.12
P/FCF 63.14
P/OCF 45.5
P/B 1.44
P/tB 1.44
EV/EBITDA N/A
EPS(TTM)0.14
EY1.27%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.17
FCFY1.58%
OCF(TTM)0.24
OCFY2.2%
SpS0.09
BVpS7.66
TBVpS7.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 1.86%
ROCE 0.86%
ROIC 0.59%
ROICexc 0.6%
ROICexgc 0.6%
OM 86.1%
PM (TTM) 150.55%
GM 81.23%
FCFM 183.91%
ROA(3y)3.96%
ROA(5y)5.5%
ROE(3y)5.07%
ROE(5y)7.37%
ROIC(3y)0.44%
ROIC(5y)0.63%
ROICexc(3y)0.45%
ROICexc(5y)0.65%
ROICexgc(3y)0.45%
ROICexgc(5y)0.65%
ROCE(3y)0.65%
ROCE(5y)0.93%
ROICexcg growth 3Y-15.8%
ROICexcg growth 5Y-23.21%
ROICexc growth 3Y-15.79%
ROICexc growth 5Y-23.21%
OM growth 3Y-0.97%
OM growth 5Y-16.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 13.55
Cash Conversion N/A
Profit Quality 122.16%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 4.27
F-Score7
WACC7.81%
ROIC/WACC0.08
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)41.17%
Cap/Sales(5y)29.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)226.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.15%
Revenue growth 3Y-12.91%
Revenue growth 5Y-2.96%
Sales Q2Q%0.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y144.23%
EBIT growth 3Y-13.76%
EBIT growth 5Y-18.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y240.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y549.3%
OCF growth 3Y-22.79%
OCF growth 5Y-21.99%